| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 150,290 | 173,151 | 190,100 | 189,920 | | Cost of Revenue | 113,810 | 131,536 | 134,883 | 144,215 | | | Gross Profit | 36,480 | 41,615 | 55,217 | 45,706 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 31,309 | 41,910 | 43,188 | 40,411 | | Non Recurring | 1,987 | 891 | 1,271 | 70,148 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,184 | (1,186) | 10,758 | (64,853) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 1,269 | | Earnings Before Interest And Taxes | (3,298) | (1,186) | 10,758 | (63,585) | | Interest Expense | (4,590) | 2,144 | 2,446 | 4,269 | | Income Before Tax | 1,292 | (3,330) | 8,312 | (67,854) | | Income Tax Expense | 40 | (1,929) | 3,210 | (8,782) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,252 | (1,401) | 5,102 | (59,072) | | | Non-recurring Events | | Discontinued Operations | (6,577) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (5,325) | (1,401) | 5,102 | (59,072) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,325) | ($1,401) | $5,102 | ($59,072) |
|
0.51% Nasdaq 
Income Statement
